After several delays, the Food and Drug Administration said last year it would to issue a new rule by the end of this month to require generic drug makers to update their warning labels in ...

In a 5-4 decision, the court said patients therefore can’t sue the maker of a generic drug over the fact that a particular warning wasn’t on its label. Allowing those suits to proceed would ...